Zobrazeno 1 - 10
of 205
pro vyhledávání: '"Ulf Meier-Kriesche"'
Qualifying a Novel Clinical Trial Endpoint (iBOX) Predictive of Long-Term Kidney Transplant Outcomes
Autor:
Amanda Klein, Alexandre Loupy, Mark Stegall, Ilkka Helanterä, Luke Kosinski, Eric Frey, Olivier Aubert, Gillian Divard, Kenneth Newell, Herwig-Ulf Meier-Kriesche, Roslyn Mannon, Thomas Dumortier, Varun Aggarwal, Jagdeep T. Podichetty, Inish O’Doherty, Ahmed Osama Gaber, William E. Fitzsimmons
Publikováno v:
Transplant International, Vol 36 (2023)
New immunosuppressive therapies that improve long-term graft survival are needed in kidney transplant. Critical Path Institute’s Transplant Therapeutics Consortium received a qualification opinion for the iBOX Scoring System as a novel secondary ef
Externí odkaz:
https://doaj.org/article/30625a9a0ea742bbb206416f92a9eb5a
Autor:
Misbah A. Moten, Sanjeev Akkina, Arman Faravardeh, Samir J. Patel, Ulf Meier-Kriesche, Suphamai Bunnapradist, Rafael Villicana, Giselle Guerra, Daniel R. Stevens
Publikováno v:
Annals of Transplantation
BACKGROUND The pharmacokinetics and metabolism of tacrolimus, an immunosuppressant commonly used to prevent transplant rejection, can differ in specific subpopulations. This analysis examined treatment outcomes and safety of immediate-release tacroli
Autor:
Klemens Budde, Claudio Procaccianti, Roberto Morganti, Ulf Meier-Kriesche, Daniel R. Stevens, Barbara Suwelack, Suphamai Bunnapradist
Publikováno v:
Annals of Transplantation
Background A previous phase 3 clinical trial in de novo adult kidney transplant recipients (NCT01187953) compared the efficacy and safety of once-daily LCP-tacrolimus (LCPT) and twice-daily immediate-release tacrolimus (IR-Tac). However, whether the
Autor:
Daniel R. Stevens, Misbah A. Moten, Daniel C. Brennan, Ulf Meier-Kriesche, Elizabeth Cohen, Jeremiah D. Momper, Jennifer Trofe-Clark, Janice Kerr, Rita R. Alloway
Publikováno v:
Therapeutic drug monitoring. 42(5)
BACKGROUND A modified-release version of tacrolimus, LCP-tacrolimus (LCPT; Envarsus XR, Veloxis Pharmaceuticals, Cary, NC), has been licensed in the United States for prophylaxis of organ rejection in de novo kidney transplant patients. As tacrolimus
Autor:
Erin M. Dunbar, Mathew P. Buzzeo, Jeff B. Levine, Jesse D. Schold, Herwig-Ulf Meier-Kriesche, Vijay Reddy
Publikováno v:
Haematologica, Vol 93, Iss 12 (2008)
Background Natural killer cells are known to have anti-tumor activity in haploidentical hematopoietic stem cell transplantation. We hypothesized that reconstituted circulating natural killer cells may be associated with improved relapse-free survival
Externí odkaz:
https://doaj.org/article/6c005f8e810945df91a671b965645bc0
Publikováno v:
In American Journal of Transplantation February 2005 5(2):207-217
Autor:
Herwig Ulf Meier-Kriesche, Jie Zheng, Kenneth E. Lamb, Kenneth B. Schechtman, Vikas R. Dharnidharka
Publikováno v:
Pediatric Transplantation. 19:471-476
Univariate analyses suggest that adolescents have worse long-term allograft survival versus younger children across different SOT. This study's objective was to determine whether multivariate analyses of a large national database recording all deceas
Publikováno v:
Seminars in Nephrology. 33:34-43
Obesity is an increasingly common comorbidity at the time of kidney transplantation. Obesity is also a frequent complication of kidney transplantation. The obese transplant recipient suffers adverse metabolic and cardiovascular consequences of obesit
Autor:
David Horn, Kieren A. Marr, William J. Steinbach, Shun Ping Quan, Nkechi Azie, Elias Anaissie, Senu Apewokin, Herwig Ulf Meier-Kriesche
Publikováno v:
Journal of Infection. 65:453-464
Summary Objectives The study investigated the epidemiology and outcome of invasive aspergillosis (IA), an important cause of morbidity and mortality in immunocompromised patients. Methods Cases of proven/probable IA from the Prospective Antifungal Th
Publikováno v:
American Journal of Transplantation. 12:2774-2780
Organ storage techniques have been under scrutiny to determine the best preservation method, particularly in donation after cardiac death (DCD) kidneys. Conflicting literature on the benefit of pulsatile perfusion (PP) over cold storage (CS) warrants